Clearproof Spot Solution for Acne-Prone Skin

Description

This product is a clear proof spot solution specifically formulated for acne-prone skin. It is provided in a 29 g dosage form, designed to target and treat blemishes effectively.

Uses and Indications

This drug is indicated for the treatment of acne-prone skin. It is formulated as a spot solution to target localized areas of acne effectively.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

On clean skin, the medication should be applied once daily to the affected areas. During the first week of treatment, a small amount should be used once daily on alternate days. Following this initial period, the frequency of application may be increased to up to three times daily if deemed necessary.

In the event of skin irritation or increased sensitivity, it is recommended to reduce the frequency of applications accordingly. Care should be taken to ensure that the application is performed on clean skin to optimize the effectiveness of the treatment.

Contraindications

The product is contraindicated in the following situations:

Use is not recommended in children. Application to the eyelids, edges of the nose and mouth, or to irritated or damaged skin is prohibited due to the potential for adverse reactions.

During pregnancy, consultation with a healthcare professional is advised prior to use. Sun exposure should be avoided while using this product to prevent skin irritation. The product must be kept out of the reach of children and should not be ingested. In the event of accidental eye contact, it is essential to rinse thoroughly with water. If irritation occurs, discontinue use and seek medical advice.

Warnings and Precautions

This product is intended for external use only and is contraindicated for use in children. It should not be applied to the eyelids, the edges of the nose and mouth, or to any irritated or damaged skin. Care should be taken to avoid the eye area during application.

Healthcare professionals are advised to counsel patients regarding the use of this product during pregnancy; a consultation with a physician is recommended prior to use. Additionally, patients should be instructed to avoid sun exposure while using this product to minimize the risk of adverse effects.

During initial applications, patients may experience a transient burning sensation, as well as itchy or dry skin. Should these symptoms persist, it is imperative that the patient discontinue use and seek medical advice.

It is essential to keep this product out of the reach of children and to emphasize that it should not be ingested. In the event of accidental contact with the eyes, patients should rinse thoroughly with water. If any irritation develops, the patient should discontinue use and consult a healthcare professional for further evaluation and guidance.

Side Effects

Patients using this product may experience a range of adverse reactions, which can be categorized based on their seriousness and frequency.

Serious adverse reactions include severe irritation or allergic reactions, particularly if the product is applied to sensitive areas such as the eyelids, edges of the nose and mouth, or to irritated or damaged skin. In the event of accidental contact with the eyes, patients should rinse thoroughly with water and seek medical advice if irritation persists.

Common adverse reactions reported during initial applications include a transient burning sensation, as well as symptoms such as itchy or dry skin. These reactions are typically mild and may resolve with continued use; however, if discomfort persists, patients are advised to discontinue use and consult their doctor.

It is important to note that this product is for external use only and should not be used on children. Patients are also cautioned to avoid sun exposure while using the product and to consult their doctor if they are pregnant. Additionally, the product should be kept out of the reach of children and should not be ingested. If any irritation develops, patients should discontinue use and seek medical advice.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Clearproof Spot Solution for Acne-Prone Skin (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should not use this medication. It is essential to keep the product out of the reach of children and to ensure that it is not ingested.

Geriatric Use

Elderly patients should be aware that this product is not intended for use in children. When considering the use of this product during pregnancy, it is essential for geriatric patients to consult their healthcare provider for guidance.

During initial applications, elderly patients may experience a transient burning sensation or symptoms such as itchy or dry skin. If these discomforts persist, it is advised to discontinue use of the product and seek medical consultation. Careful monitoring of skin reactions is recommended to ensure safety and efficacy in this population.

Pregnancy

Pregnant patients are advised to consult their healthcare provider regarding the use of this medication during pregnancy. The potential risks and benefits should be carefully considered, as the effects on fetal outcomes are not fully established. It is essential for women of childbearing potential to discuss their pregnancy status and any plans for pregnancy with their healthcare provider prior to initiating treatment.

Lactation

Lactating mothers should consult their healthcare provider regarding the use of this medication during breastfeeding. There is no specific data available on the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, careful consideration and professional guidance are recommended before use in lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of overdosage, it is imperative to keep the product out of the reach of children to prevent accidental ingestion. Ingestion of the product can lead to serious health consequences.

Healthcare professionals should be vigilant for potential symptoms associated with overdosage, which may vary depending on the specific circumstances and the amount ingested.

Management of overdosage should include immediate medical evaluation. It is recommended that healthcare providers follow established protocols for the assessment and treatment of overdose cases, which may involve supportive care and symptomatic treatment as necessary.

Prompt intervention is crucial to mitigate any adverse effects resulting from overdosage.

Nonclinical Toxicology

For use during pregnancy, it is advised to consult a healthcare professional regarding potential teratogenic effects. No information is available regarding non-teratogenic effects. Additionally, there are no details provided concerning animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to apply the product once a day to clean skin, specifically targeting the affected areas. During the first week of use, patients should be instructed to apply a small amount on alternate days. If necessary, the frequency of application may be increased to up to three times a day.

Patients should be informed that if they experience any irritation or increased skin sensitivity, they should reduce the frequency of application. It is important to emphasize that the product is for external use only and should not be used on children. Additionally, patients should be cautioned against applying the product to the eyelids, the edges of the nose and mouth, or any irritated or damaged skin, and to avoid the eye area altogether.

For patients who are pregnant, it is essential to recommend consulting their doctor before using the product. Patients should also be advised to avoid sun exposure while using this product to minimize the risk of adverse effects.

During the initial applications, patients may experience a transient burning sensation or symptoms such as itchy or dry skin. If these discomforts persist, they should discontinue use and consult their doctor. It is crucial to keep the product out of the reach of children and to instruct patients not to ingest it. In the event of accidental contact with the eyes, patients should rinse thoroughly with water. If any irritation develops, they should discontinue use and seek medical advice.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with a recommended application of once daily to clean skin on affected areas. During the first week, a small amount should be applied once daily on alternate days, with the frequency potentially increasing to up to three times a day if necessary.

Clinicians should counsel patients to consult their doctor regarding use during pregnancy and to avoid sun exposure while using the product. Patients may experience a transient burning sensation or itchy, dry skin during initial applications; if discomfort persists, they should discontinue use and seek medical advice. In the event of accidental eye contact, thorough rinsing with water is advised, and any development of irritation should prompt discontinuation of use and consultation with a healthcare professional.

Drug Information (PDF)

This file contains official product information for Clearproof Spot Solution for Acne-Prone Skin, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)